The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 329:1912-1917 December 23, 1993 Number 26
NextNext

The Natural History of Borderline Isolated Systolic Hypertension
Alex Sagie, Martin G. Larson, and Daniel Levy

 Sign up for free e-toc
 

This Article
-Full Text

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Patients with isolated systolic hypertension are at increased risk for cardiovascular disorders. We attempted to determine whether those with borderline isolated systolic hypertension (defined as a systolic blood pressure of 140 to 159 mm Hg and a diastolic blood pressure below 90 mm Hg) have a greater risk of progression to definite (more severe) hypertension and of major morbid or fatal events than people with normal blood pressure (<140/90 mm Hg).

Methods A total of 2767 of the original participants in the Framingham Heart Study were monitored with biennial examinations for up to 34 years for the development of definite hypertension (defined as a systolic blood pressure of >= 160 mm Hg, a diastolic blood pressure of >= 90 mm Hg, or the initiation of antihypertensive therapy) and for major cardiovascular events.

Results Borderline isolated systolic hypertension was the most common type of untreated hypertension among adults over the age of 60. After 20 years of follow-up, 80 percent of those with borderline isolated systolic hypertension had progression to definite hypertension, as compared with 45 percent of the normotensive participants (P<0.001). After adjustment for age, sex, and risk factors for cardiovascular disease, participants with borderline isolated systolic hypertension had an excess long-term risk of cardiovascular disease (hazard ratio, 1.47; 95 percent confidence interval, 1.24 to 1.74) and death from cardiovascular disease (hazard ratio, 1.57; 95 percent confidence interval, 1.24 to 2.00), as compared with normotensive participants. In an analysis of pooled data from biennial examinations to study short-term sequelae, subjects with borderline isolated systolic hypertension had an increased risk of progression to definite hypertension (odds ratio, 3.84; 95 percent confidence interval, 3.35 to 4.41) and of cardiovascular disease (odds ratio, 1.39; 95 percent confidence interval, 1.06 to 1.82).

Conclusions In both the short term and the long term, subjects with borderline isolated systolic hypertension are at increased risk of progression to definite hypertension and the development of cardiovascular disease.


Source Information

From the Framingham Heart Study, Framingham, Mass. (A.S., M.G.L., D.L.); the National Heart, Lung, and Blood Institute, Bethesda, Md. (M.G.L., D.L.); the Divisions of Epidemiology and Preventive Medicine, Boston University School of Medicine, Boston (D.L.); and the Divisions of Cardiology and Clinical Epidemiology, Beth Israel Hospital, Boston (D.L.). Dr. Sagie was a visiting Research Fellow from Beilinson Medical Center, Petah Tikva, Israel, and the Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel.Presented at the 66th Scientific Sessions of the American Heart Association, November 8-11, 1993.

Address reprint requests to Dr. Levy at the Framingham Heart Study, 5 Thurber St., Framingham, MA 01701.

Full Text of this Article


Related Letters:

Borderline Systolic Hypertension
Selverstone N. J., Sagie A., Larson M. G., Levy D.
Extract | Full Text  
N Engl J Med 1994; 330:1392, May 12, 1994. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.